|
Dr. Garland, 60, was Executive Vice President of Pharmaceutical Development with Centaur Pharmaceuticals, a development-stage Silicon Valley biopharmaceutical company from 1994 to 2000. There he was responsible for progressing three projects from discovery stage to Phase II clinical testing, and helped manage the growth of Centaur from fewer than a dozen employees to more than 100 employees. Dr. Garland spent 20 years with Hoffmann-La Roche in New Jersey. From 1991-1994, Dr. Garland was Senior Director and U.S. Head of International Project Management. Before joining AngioGenex, he was Vice President for Scientific Affairs at Atairgin Technologies, an emerging health-care technology company. Dr. Garland received a Ph.D. in medicinal chemistry from the University of Washington and is a member of the BOD of lPath Therapeutics, San Diego.
| 